The Flow Cytometry Shared Resource at the HICCC supports a wide variety of studies related to cancer biology, functional genomics and tumor immunology using the newest techniques.
The High Throughput Screening shared resource is equipped with state-of-the-art instrumentation, robotic automation, and software for running high-throughput screens using assay technologies.
Meet new HICCC member, Dr. Alison Taylor, whose work explores the role of aneuploidy and how these specific sets of chromosome mutations contribute to tumor development.
The Molecular Pathology Shared Resource (MPSR) is a comprehensive service for researchers and scientists conducting cutting-edge experimental, basic science, and translational research at the HICCC.
In a span of just a few weeks, Kenneth Olive, PhD, has galvanized a team of volunteers—primarily students, postdocs, and staff scientists—to assist with the surging COVID-19 response across CUIMC.
CovidWatcher works as a crowd-sourcing research platform that surveys users—both healthy and potentially exposed to COVID-19—about their exposure to the virus, symptoms, and access to medical care.
The Association of American Physicians (AAP), an honorific society of the nation’s leading physician-scientists, has inducted two HICCC members, Charles Drake, MD, PhD, and Adolfo Ferrando, MD, PhD.
Researchers from the Herbert Irving Comprehensive Cancer Center (HICCC) at NewYork-Presbyterian/Columbia are swiftly transforming their discoveries and innovation in cancer to address COVID-19.
